Candel Therapeutics Stock Technical Analysis
| CADL Stock | USD 4.71 0.00 0.00% |
As of the 29th of November, Candel Therapeutics shows the Mean Deviation of 3.31, risk adjusted performance of (0.02), and Standard Deviation of 4.75. Candel Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Candel Therapeutics variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Candel Therapeutics is priced correctly, providing market reflects its regular price of 4.71 per share. Given that Candel Therapeutics has information ratio of (0.06), we suggest you to validate Candel Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.
Candel Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Candel, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CandelCandel |
Candel Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 9.5 | Strong Sell | 0 | Odds |
Most Candel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Candel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Candel Therapeutics, talking to its executives and customers, or listening to Candel conference calls.
Candel Analyst Advice DetailsCandel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Candel Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Candel Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Candel Therapeutics Trend Analysis
Use this graph to draw trend lines for Candel Therapeutics. You can use it to identify possible trend reversals for Candel Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Candel Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Candel Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Candel Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.05 , which may suggest that Candel Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 108.89, which is the sum of squared deviations for the predicted Candel Therapeutics price change compared to its average price change.About Candel Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Candel Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Candel Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Candel Therapeutics price pattern first instead of the macroeconomic environment surrounding Candel Therapeutics. By analyzing Candel Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Candel Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Candel Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 15.84 | 12.81 | 2.59 | 2.46 | Net Debt To EBITDA | 3.22 | 2.73 | 0.34 | 0.32 |
Candel Therapeutics November 29, 2024 Technical Indicators
Most technical analysis of Candel help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Candel from various momentum indicators to cycle indicators. When you analyze Candel charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 3.31 | |||
| Coefficient Of Variation | (3,098) | |||
| Standard Deviation | 4.75 | |||
| Variance | 22.6 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.88) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 26.28 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 6.7 | |||
| Skewness | 1.52 | |||
| Kurtosis | 6.14 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.73) | Revenue Per Share 0.001 | Return On Assets (0.52) | Return On Equity (4.81) |
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.